๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Octreotide therapy for chylous ascites in a chronic dialysis patient

โœ Scribed by PEI-HSIEN LEE; CHUN-LIANG LIN; PING-CHIN LAI; CHIH-WEI YANG

Book ID
108958952
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
144 KB
Volume
10
Category
Article
ISSN
1320-5358

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Octreotide for relapsing sulfonylurea-in
Octreotide for relapsing sulfonylurea-induced hypoglycemia in a dialysis patient
โœ Arash Yavari; Marlies Ostermann; Douglas MacLean; John Scoble ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 95 KB

## Abstract ## BACKGROUND Hypoglycemia is the principle adverse effect of sulfonylurea, especially in patients with renal failure. Conventional treatment consists of hypertonic dextrose, sometimes combined with glucagon. However, paradoxically both agents can stimulate insulin secretion and induce